Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Total 13F shares
-
279,155,505
-
Share change
-
+757,392
-
Total reported value
-
$6,445,326,162
-
Put/Call ratio
-
97%
-
Price per share
-
$23.09
-
Number of holders
-
267
-
Value change
-
+$41,955,777
-
Number of buys
-
124
-
Number of sells
-
123
Institutional Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q4 2020
As of 31 Dec 2020,
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) was held by
267 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
279,155,505 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, BlackRock Inc., Redmile Group, LLC, MORGAN STANLEY, JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC, JPMORGAN CHASE & CO, and STATE STREET CORP.
This page lists
267
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.